medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/ms2023-364medsovet-7837Research ArticleАЛЛЕРГОЛОГИЯ И ИММУНОЛОГИЯALLERGOLOGY AND IMMUNOLOGYПрактические вопросы применения эмолентов с целью профилактики обострений атопического дерматита в сезон цветения: резолюция экспертовPractical issues of using emollients for the prevention of exacerbations of atopic dermatitis during the flowering season: expert resolutionhttps://orcid.org/0000-0003-3358-5087ФеденкоЕ. С.FedenkoE. S.

Феденко Елена Сергеевна, доктор медицинских наук, профессор, заведующая поликлиническим отделением

115478, Москва, Каширское шоссе, д. 24

Elena S. Fedenko, Dr. Sci. (Med.), Professor, Head of Outpatient Department

24, Kashirskoye Shosse, Moscow, 115478

efedks@gmail.comhttps://orcid.org/0000-0003-4200-4598ЗахароваИ. Н.ZakharovaI. N.

Захарова Ирина Николаевна, доктор медицинских наук, профессор, заведующая кафедрой педиатрии имени академика Г.Н. Сперанского

125993, Москва, ул. Баррикадная, д. 2/1, стр. 1

Irina N. Zakharova, Dr. Sci. (Med.), Professor, Head of the Department of Pediatrics named after Academician G.N. Speransky

2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993

kafedra25@yandex.ruhttps://orcid.org/0000-0003-3426-3426ЗайцеваО. В.ZaytsevaO. V.

Зайцева Ольга Витальевна, доктор медицинских наук, профессор, заведующая кафедрой педиатрии

127006, Москва, ул. Долгоруковская, д. 4

Olga V. Zaytseva, Dr. Sci. (Med.), Professor, Head of the Department of Pediatrics

4, Dolgorukovskaya St., Moscow, 127473

olga6505963@yandex.ruhttps://orcid.org/0000-0001-5039-8473ПампураА. Н.PampuraA. N.

Пампура Александр Николаевич, доктор медицинских наук, профессор, руководитель отдела аллергологии и клинической иммунологии, Научно-исследовательский клинический институт педиатрии и детской хирургии имени академика Ю.Е. Вельтищева

125412, Москва, ул. Талдомская, д. 2

Alexander N. Pampura, Dr. Sci. (Med.), Professor, Head of the Department of Allergology and Clinical Immunology, Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery

2, Taldomskaya St., Moscow, 125412

apampura@pedklin.ruhttps://orcid.org/0000-0003-3261-6718ТамразоваО. Б.TamrazovaO. B.

Тамразова Ольга Борисовна, доктор медицинских наук, профессор, профессор кафедры дерматовенерологии с курсом косметологии

117198, Москва, ул. Миклухо-Маклая, д. 6

Olga B. Tamrazova, Dr. Sci. (Med.), Professor, Рrofessor of the Department of Dermatovenerology with a course of Сosmetology

6, Miklukho-Maklai St., Moscow, 117198

anait_tamrazova@mail.ruГосударственный научный центр «Институт иммунологии»РоссияNational Research Center – Institute of ImmunologyRussian FederationРоссийская медицинская академия непрерывного профессионального образованияРоссияRussian Medical Academy of Continuous Professional EducationRussian FederationМосковский государственный медико-стоматологический университет имени А.И. ЕвдокимоваРоссияYevdokimov Moscow State University of Medicine and DentistryRussian FederationРоссийская медицинская академия непрерывного профессионального образования; Научно-исследовательский клинический институт педиатрии и детской хирургии имени академика Ю.Е. ВельтищеваРоссияRussian Medical Academy of Continuous Professional Education; Veltischev Research and Clinical Institute for Pediatrics and Pediatric SurgeryRussian FederationРоссийский университет дружбы народов имени Патриса ЛумумбыРоссияPeoples’ Friendship University of Russia named after Patrice LumumbaRussian Federation202301112023017Педиатрия172178Copyright © Феденко Е.С., Захарова И.Н., Зайцева О.В., Пампура А.Н., Тамразова О.Б., 20232023Феденко Е.С., Захарова И.Н., Зайцева О.В., Пампура А.Н., Тамразова О.Б.Fedenko E.S., Zakharova I.N., Zaytseva O.V., Pampura A.N., Tamrazova O.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/7837

В феврале 2023 г. состоялось совещание Совета экспертов, в котором приняли участие ведущие специалисты в области аллергологии, педиатрии и дерматовенерологии. Рабочая группа обсудила проблемы сенсибилизации к пыльцевым аллергенам у пациентов с атопическим дерматитом (АтД) и обострения заболевания в период цветения растений, а также формирования чрескожной сенсибилизации через поврежденный эпидермальный барьер. Основываясь на данных ранее проведенных исследований, эксперты пришли к соглашению, что контакт кожи больных АтД с пыльцевыми аллергенами в период цветения растений может негативно влиять на течение заболевания даже у больных, не имеющих соответствующей IgE-сенсибилизации. Эксперты комплексно рассмотрели критерии, которым должен отвечать современный эмолент, применяемый для ухода за кожей больных АтД, обсудили ключевые компоненты эмолентов плюс и их функцию, роль увлажняющих средств в профилактике сезонных обострений АтД на основании проведенного ранее исследования и выработали единые рекомендации о принципах ведения пациентов с АтД в сезон цветения растений. В ходе совещания эксперты пришли к выводу о необходимости разработки единых подходов к диагностике и лечению пациентов с АтД и пыльцевой сенсибилизацией и их внедрения в клиническую практику. Высказаны предложения о дальнейших информационных и организационных мероприятиях, направленных на расширение знаний пациентов и врачей о проблеме чрескожной сенсибилизации к аэроаллергенам у больных АтД, их роли в развитии сезонных обострений и возможности их профилактики с использованием современных эмолентов.

In February 2023, a meeting of the Council of Experts was held, attended by leading specialists in the fields of allergology, pediatrics and dermatology. The Working Group discussed the problem of sensitization to pollen allergens in patients with atopic dermatitis and exacerbation of the disease during the pollination season of plants, as well as the formation of epicutaneous sensitization through a damaged epidermal barrier. The experts comprehensively considered the criteria that a modern emollient used for the care of atopic dermatitis patients’ skin should meet, discussed the role of moisturizers in preventing seasonal exacerbations of atopic dermatitis based on previously conducted research, and developed unified recommendations on the principles of managing this type of patients. Suggestions were made for further informational and organizational measures aimed at expanding the knowledge of patients and medical specialists about the problem of epicutaneous sensitization to aeroallergens in atopic dermatitis patients, their role in the development of seasonal exacerbations of atopic dermatitis, and the possibility of their prevention using modern emollients.

атопический дерматитэмолентыэпидермальный барьерпыльцевая аллергиячрескожная сенсибилизацияatopic dermatitisemollientsepidermal barrierpollen allergycutaneous sensitizationReferencesКубанов АА, Намазова-Баранова ЛС, Хаитов РМ, Ильина НИ, Алексеева ЕА, Амбарчян ЭТ и др. Атопический дерматит: клинические рекомендации. М.; 2021. 81 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/265_2.Кубанов АА, Намазова-Баранова ЛС, Хаитов РМ, Ильина НИ, Алексеева ЕА, Амбарчян ЭТ и др. Атопический дерматит: клинические рекомендации. М.; 2021. 81 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/265_2.Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl. 1):8–16. https://doi.org/10.1159/000370220.Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl. 1):8–16. https://doi.org/10.1159/000370220.Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–992. https://doi.org/10.1111/j.1742-1241.2006.01047.x.Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–992. https://doi.org/10.1111/j.1742-1241.2006.01047.x.Liang Y, Chang C, Lu Q. The Genetics and Epigenetics of Atopic DermatitisFilaggrin and Other Polymorphisms. Clin Rev Allergy Immunol. 2016;51(3):315–328. https://doi.org/10.1007/s12016-015-8508-5.Liang Y, Chang C, Lu Q. The Genetics and Epigenetics of Atopic DermatitisFilaggrin and Other Polymorphisms. Clin Rev Allergy Immunol. 2016;51(3):315–328. https://doi.org/10.1007/s12016-015-8508-5.Birben E, Sackesen C, Turgutoğlu N, Kalayci O. The role of SPINK5 in asthma related physiological events in the airway epithelium. Respir Med. 2012;106(3):349–355. https://doi.org/10.1016/j.rmed.2011.11.007.Birben E, Sackesen C, Turgutoğlu N, Kalayci O. The role of SPINK5 in asthma related physiological events in the airway epithelium. Respir Med. 2012;106(3):349–355. https://doi.org/10.1016/j.rmed.2011.11.007.Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018;67(1):3–11. https://doi.org/10.1016/j.alit.2017.10.002.Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018;67(1):3–11. https://doi.org/10.1016/j.alit.2017.10.002.Ständer S. Atopic Dermatitis. N Engl J Med. 2021;384(12):1136–1143. https://doi.org/10.1056/NEJMra2023911.Ständer S. Atopic Dermatitis. N Engl J Med. 2021;384(12):1136–1143. https://doi.org/10.1056/NEJMra2023911.Li H, Zhang Z, Zhang H, Guo Y, Yao Z. Update on the Pathogenesis and Therapy of Atopic Dermatitis. Clin Rev Allergy Immunol. 2021;61(3):324–338. https://doi.org/10.1007/s12016-021-08880-3.Li H, Zhang Z, Zhang H, Guo Y, Yao Z. Update on the Pathogenesis and Therapy of Atopic Dermatitis. Clin Rev Allergy Immunol. 2021;61(3):324–338. https://doi.org/10.1007/s12016-021-08880-3.Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017;13(1):15–26. https://doi.org/10.1080/1744666X.2016.1212660.Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017;13(1):15–26. https://doi.org/10.1080/1744666X.2016.1212660.Hostetler SG, Kaffenberger B, Hostetler T, Zirwas MJ. The role of airborne proteins in atopic dermatitis. J Clin Aesthet Dermatol. 2010;3(1):22–31. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921737/.Hostetler SG, Kaffenberger B, Hostetler T, Zirwas MJ. The role of airborne proteins in atopic dermatitis. J Clin Aesthet Dermatol. 2010;3(1):22–31. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921737/.Serhan N, Basso L, Sibilano R, Petitfils C, Meixiong J, Bonnart C et al. House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. Nat Immunol. 2019;20(11):1435–1443. https://doi.org/10.1038/s41590-019-0493-z.Serhan N, Basso L, Sibilano R, Petitfils C, Meixiong J, Bonnart C et al. House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. Nat Immunol. 2019;20(11):1435–1443. https://doi.org/10.1038/s41590-019-0493-z.Werfel T, Heratizadeh A, Niebuhr M, Kapp A, Roesner LM, Karch A et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136(1):96–103.e9. https://doi.org/10.1016/j.jaci.2015.04.015.Werfel T, Heratizadeh A, Niebuhr M, Kapp A, Roesner LM, Karch A et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136(1):96–103.e9. https://doi.org/10.1016/j.jaci.2015.04.015.Fölster-Holst R, Galecka J, Weißmantel S, Dickschat U, Rippke F, Bohnsack K et al. Birch pollen influence the severity of atopic eczema - prospective clinical cohort pilot study and ex vivo penetration study. Clin Cosmet Investig Dermatol. 2015;8:539–548. https://doi.org/10.2147/CCID.S81700.Fölster-Holst R, Galecka J, Weißmantel S, Dickschat U, Rippke F, Bohnsack K et al. Birch pollen influence the severity of atopic eczema - prospective clinical cohort pilot study and ex vivo penetration study. Clin Cosmet Investig Dermatol. 2015;8:539–548. https://doi.org/10.2147/CCID.S81700.Knaysi G, Smith AR, Wilson JM, Wisniewski JA. The Skin as a Route of Allergen Exposure: Part II. Allergens and Role of the Microbiome and Environmental Exposures. Curr Allergy Asthma Rep. 2017;17(1):7. https://doi.org/10.1007/s11882-017-0675-4.Knaysi G, Smith AR, Wilson JM, Wisniewski JA. The Skin as a Route of Allergen Exposure: Part II. Allergens and Role of the Microbiome and Environmental Exposures. Curr Allergy Asthma Rep. 2017;17(1):7. https://doi.org/10.1007/s11882-017-0675-4.Brough HA, Nadeau KC, Sindher SB, Alkotob SS, Chan S, Bahnson HT et al. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented? Allergy. 2020;75(9):2185–2205. https://doi.org/10.1111/all.14304.Brough HA, Nadeau KC, Sindher SB, Alkotob SS, Chan S, Bahnson HT et al. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented? Allergy. 2020;75(9):2185–2205. https://doi.org/10.1111/all.14304.Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol. 2004;34(8):2100–2109. https://doi.org/10.1002/eji.200425196.Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol. 2004;34(8):2100–2109. https://doi.org/10.1002/eji.200425196.Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3(7):673–680. https://doi.org/10.1038/ni805.Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3(7):673–680. https://doi.org/10.1038/ni805.Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol. 2010;126(5):976–984. https://doi.org/10.1016/j.jaci.2010.08.041.Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol. 2010;126(5):976–984. https://doi.org/10.1016/j.jaci.2010.08.041.Tordesillas L, Goswami R, Benedé S, Grishina G, Dunkin D, Järvinen KM et al. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest. 2014;124(11):4965–4975. https://doi.org/10.1172/JCI75660.Tordesillas L, Goswami R, Benedé S, Grishina G, Dunkin D, Järvinen KM et al. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest. 2014;124(11):4965–4975. https://doi.org/10.1172/JCI75660.Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy. 2012;67(9):1118–1126. https://doi.org/10.1111/j.1398-9995.2012.02859.x.Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy. 2012;67(9):1118–1126. https://doi.org/10.1111/j.1398-9995.2012.02859.x.Wassmann-Otto A, Heratizadeh A, Wichmann K, Werfel T. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis. Allergy. 2018;73(10):2046–2054. https://doi.org/10.1111/all.13454.Wassmann-Otto A, Heratizadeh A, Wichmann K, Werfel T. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis. Allergy. 2018;73(10):2046–2054. https://doi.org/10.1111/all.13454.Reekers R, Busche M, Wittmann M, Kapp A, Werfel T. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol. 1999;104(2 Pt 1):466–472. https://doi.org/10.1016/s0091-6749(99)70395-7.Reekers R, Busche M, Wittmann M, Kapp A, Werfel T. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol. 1999;104(2 Pt 1):466–472. https://doi.org/10.1016/s0091-6749(99)70395-7.De Bruin-Weller M, Gadkari A, Auziere S, Simpson EL, Puig L, Barbarot S et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada. J Eur Acad Dermatol Venereol. 2020;34(5):1026–1036. https://doi.org/10.1111/jdv.16003.De Bruin-Weller M, Gadkari A, Auziere S, Simpson EL, Puig L, Barbarot S et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada. J Eur Acad Dermatol Venereol. 2020;34(5):1026–1036. https://doi.org/10.1111/jdv.16003.Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, FinkWagner A et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. https://doi.org/10.1111/jdv.14891.Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, FinkWagner A et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. https://doi.org/10.1111/jdv.14891.Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. https://doi.org/10.1016/j.jaad.2014.03.023.Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. https://doi.org/10.1016/j.jaad.2014.03.023.Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–1060. https://doi.org/10.1111/j.1468-3083.2012.04635.x.Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–1060. https://doi.org/10.1111/j.1468-3083.2012.04635.x.Giménez-Arnau A. Standards for the Protection of Skin Barrier Function. In: Agner T (ed.). Skin Barrier Function. Karger; 2016, pp. 123–134. https://doi.org/10.1159/000441588.Giménez-Arnau A. Standards for the Protection of Skin Barrier Function. In: Agner T (ed.). Skin Barrier Function. Karger; 2016, pp. 123–134. https://doi.org/10.1159/000441588.Guéniche A, Dahel K, Bastien P, Martin R, Nicolas JF, Breton L. Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms. J Eur Acad Dermatol Venereol. 2008;22(6):746–747. https://doi.org/10.1111/j.1468-3083.2007.02428.x.Guéniche A, Dahel K, Bastien P, Martin R, Nicolas JF, Breton L. Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms. J Eur Acad Dermatol Venereol. 2008;22(6):746–747. https://doi.org/10.1111/j.1468-3083.2007.02428.x.Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebocontrolled clinical study. Br J Dermatol. 2008;159(6):1357–1363. https://doi.org/10.1111/j.1365-2133.2008.08836.x.Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebocontrolled clinical study. Br J Dermatol. 2008;159(6):1357–1363. https://doi.org/10.1111/j.1365-2133.2008.08836.x.Mainzer C, Le Guillou M, Vyumvuhore R, Chadoutaud B, Bordes S, Closs B. Clinical Efficacy of Oligofructans from Ophiopogon japonicus in Reducing Atopic Dermatitis Flare-ups in Caucasian Patients. Acta Derm Venereol. 2019;99(10):858–864. https://doi.org/10.2340/00015555-3224.Mainzer C, Le Guillou M, Vyumvuhore R, Chadoutaud B, Bordes S, Closs B. Clinical Efficacy of Oligofructans from Ophiopogon japonicus in Reducing Atopic Dermatitis Flare-ups in Caucasian Patients. Acta Derm Venereol. 2019;99(10):858–864. https://doi.org/10.2340/00015555-3224.Meinke MC, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A et al. Prevention of follicular penetration: barrier-enhancing formulations against the penetration of pollen allergens into hair follicles. Skin Pharmacol Physiol. 2011;24(3):144–150. https://doi.org/10.1159/000323018.Meinke MC, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A et al. Prevention of follicular penetration: barrier-enhancing formulations against the penetration of pollen allergens into hair follicles. Skin Pharmacol Physiol. 2011;24(3):144–150. https://doi.org/10.1159/000323018.Lademann J, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A et al. Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions. Eur J Pharm Biopharm. 2009;72(3):600–604. https://doi.org/10.1016/j.ejpb.2009.02.003.Lademann J, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A et al. Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions. Eur J Pharm Biopharm. 2009;72(3):600–604. https://doi.org/10.1016/j.ejpb.2009.02.003.Billmann-Eberwein C, Rippke F, Ruzicka T, Krutmann J. Modulation of atopy patch test reactions by topical treatment of human skin with a fatty acid-rich emollient. Skin Pharmacol Appl Skin Physiol. 2002;15(2):100–104. https://doi.org/10.1159/000049396.Billmann-Eberwein C, Rippke F, Ruzicka T, Krutmann J. Modulation of atopy patch test reactions by topical treatment of human skin with a fatty acid-rich emollient. Skin Pharmacol Appl Skin Physiol. 2002;15(2):100–104. https://doi.org/10.1159/000049396.Литовкина АО, Смольников ЕВ, Елисютина ОГ, Феденко ЕС. Современные эмоленты в профилактике обострений атопического дерматита в сезон цветения. Российский аллергологический журнал. 2023;20(1):41–51. https://doi.org/10.36691/RJA4136.Litovkina AO, Smolnikov EV, Elisyutina OG, Fedenko ES. The role of modern emollients in prophylaxis of atopic dermatitis exacerbation during pollination season. Russian Journal of Allergy. 2023;20(1):41–51. (In Russ.) https://doi.org/10.36691/RJA4136.Luger T, Amagai M, Dreno B, Dagnelie MA, Liao W, Kabashima K et al. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci. 2021;102(3):142–157. https://doi.org/10.1016/j.jdermsci.2021.04.007.Luger T, Amagai M, Dreno B, Dagnelie MA, Liao W, Kabashima K et al. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci. 2021;102(3):142–157. https://doi.org/10.1016/j.jdermsci.2021.04.007.Lowe AJ, Su JC, Allen KJ, Abramson MJ, Cranswick N, Robertson CF et al. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study. Br J Dermatol. 2018;178(1):e19–e21. https://doi.org/10.1111/bjd.15747Lowe AJ, Su JC, Allen KJ, Abramson MJ, Cranswick N, Robertson CF et al. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study. Br J Dermatol. 2018;178(1):e19–e21. https://doi.org/10.1111/bjd.15747

The authors declare that there are no conflicts of interest present.